Parkinson's Disease

Impax, GSK end Parkinson's disease partnership

Impax, GSK end Parkinson's disease partnership

Reuters

Acadia Gets Expedited FDA Review Path for Lead Drug

Acadia Gets Expedited FDA Review Path for Lead Drug

Bloomberg

Is There Any Potential Left In ACADIA Pharmaceuticals?

Is There Any Potential Left In ACADIA Pharmaceuticals?

Seeking Alpha

Phytopharm gives up after Parkinson's drug failure

Phytopharm gives up after Parkinson's drug failure

Reuters

Cerecor gets rights to potential drugs for Parkinson's disease and other illnesses from Merck

Cerecor gets rights to potential drugs for Parkinson's disease and other illnesses from Merck

Yahoo/AP

Impax to Present Rytary Trial Data Next Week

Impax to Present Rytary Trial Data Next Week

Motley Fool

Actavis Confirms Generic Version Of Novartis' Dementia Therapy

Actavis Confirms Generic Version Of Novartis' Dementia Therapy

istockanalyst

FDA Holds Up Impax Parkinson's Drug Approval Bid

FDA Holds Up Impax Parkinson's Drug Approval Bid

Motley Fool

Impax Fails to Win Approval for Parkinson’s Drug

Impax Fails to Win Approval for Parkinson’s Drug

Bloomberg

4 Can't-Miss Health-Care Events This Week

4 Can't-Miss Health-Care Events This Week

Motley Fool